Don't use DIABETES as a CV risk equivalent
As a pharmacy doctor, you will see more consensus on using statins for diabetes patients.…
Finerenone (Kerendia) role for Diabetic Kidney Disease
As a hospital pharmacist, you will hear about a new medication finerenone ( Kerendia ) f…
Optimize management of CKD in patients with diabetes
As a clinical pharmacist, you should optimize treatment of chronic kidney disease (CKD) i…
Explaining the role of Mounjaro for Type 2 Diabetes
Mounjaro (Tirzepatide): A Novel Approach for Type 2 Diabetes Management As a pharmacy …
Insulin resistance is a BIG problem
Metabolic syndrome is a BIG problem and growing. It affects over 25% of adults and 4% of …
Ensure your DIABETIC patients are on statin
Many eligible adults with diabetes aren’t on a statin . We know that statins reduce card…
Best diet for DIABETIC patients
Overview On WORLD DIABETES DAY (14 November), the question is increasing about what is …
Using metformin in diabetes patients with kidney disease
M etformin will be used in more diabetes patients with kidney disease as FDA labeling ca…
Consider heart failure when weighing medications for diabetes
HEART FAILURE is a frequent and often fatal complication of type 2 diabetes and there wi…
Blood pressure goals and medications for patients with diabetes
All pharmacists hear continued debate about how to manage hypertension in patients with d…
Management of diabetes mellitus in primary care
SCREENING AND PREVENTION ㅡ Screen asymptomatic patients at increased risk for diabetes me…
ACE inhibitors or an ARB for hypertension or diabetic kidney disease
A shift in thinking about the cardiovascular (CV) benefits of angiotensin receptor blocke…